Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy*; D004357:Drug Synergism; D004562:Electrocardiography; D004897:Erythrityl Tetranitrate / Q000627:therapeutic use*; D005080:Exercise Test; D005500:Follow-Up Studies; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010919:Placebos; D013565:Sympatholytics; D014665:Vasodilator Agents; D004897:Erythrityl Tetranitrate; D011433:Propranolol